PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China · Delayed Price · Currency is CNY 40.01
-0.69 (-1.70%)
Apr 29, 2026, 3:04 PM CST
SHE:300725 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 196.83 | 183.74 | 219.54 | 197.36 | 314.22 | 486.56 |
Depreciation & Amortization | 139.78 | 139.78 | 131.2 | 116.09 | 88.03 | 54.99 |
Other Amortization | 4.31 | 4.31 | 7.95 | 5.49 | 6.44 | 3.83 |
Loss (Gain) From Sale of Assets | -1.15 | -1.15 | - | -0.42 | - | -0.04 |
Asset Writedown & Restructuring Costs | 32.38 | 32.38 | 1.41 | 14.8 | 20.68 | 10.41 |
Loss (Gain) From Sale of Investments | -36.28 | -36.28 | -36.46 | 7.27 | -19.89 | -238.15 |
Provision & Write-off of Bad Debts | - | - | 3.9 | 9.83 | - | - |
Other Operating Activities | -151.12 | 58.13 | 90.38 | 94.79 | 28.2 | 43.31 |
Change in Accounts Receivable | 162.08 | 162.08 | -60.11 | 37.37 | -31.42 | -133.74 |
Change in Inventory | 154.33 | 154.33 | -175.24 | -74.74 | -237.66 | -51.77 |
Change in Accounts Payable | -15.27 | -15.27 | 116.81 | -177.78 | 66.19 | 41.78 |
Change in Other Net Operating Assets | -6.5 | -6.5 | -0.35 | 15.41 | 24.95 | 32.24 |
Operating Cash Flow | 471.2 | 667.36 | 302.82 | 246.84 | 246.61 | 238.03 |
Operating Cash Flow Growth | -5.73% | 120.38% | 22.68% | 0.09% | 3.60% | -12.33% |
Capital Expenditures | -204.52 | -140.13 | -118.12 | -315.77 | -557.91 | -505.76 |
Sale of Property, Plant & Equipment | 3.65 | 3.27 | 0.01 | 2.1 | 0.28 | 0.2 |
Cash Acquisitions | - | - | - | - | - | -152.59 |
Investment in Securities | -367.4 | -83.86 | 6.54 | -626.5 | -56.04 | -276.14 |
Other Investing Activities | 43.28 | 43.92 | 35.47 | -3.61 | 20.03 | 19.94 |
Investing Cash Flow | -524.99 | -176.8 | -76.11 | -943.78 | -593.64 | -914.34 |
Long-Term Debt Issued | - | 100 | 250.01 | 466.48 | 1,998 | 290.58 |
Total Debt Issued | 100 | 100 | 250.01 | 466.48 | 1,998 | 290.58 |
Short-Term Debt Repaid | - | - | - | - | -31.52 | - |
Long-Term Debt Repaid | - | -275.01 | -630.99 | -339.39 | -708.15 | -122.98 |
Total Debt Repaid | -230 | -275.01 | -630.99 | -339.39 | -739.67 | -122.98 |
Net Debt Issued (Repaid) | -130 | -175.01 | -380.98 | 127.1 | 1,258 | 167.6 |
Repurchase of Common Stock | - | - | -10.01 | -20.03 | -1.02 | - |
Common Dividends Paid | -65.46 | -65.75 | -77.97 | -41.69 | -33.67 | -22.38 |
Other Financing Activities | -1.29 | -1.71 | - | - | -463.07 | - |
Financing Cash Flow | -196.75 | -242.46 | -468.96 | 65.37 | 760.36 | 145.22 |
Foreign Exchange Rate Adjustments | -19.33 | -5.56 | 24.17 | 1.89 | 31.99 | -17 |
Net Cash Flow | -269.87 | 242.54 | -218.07 | -629.68 | 445.33 | -548.09 |
Free Cash Flow | 266.68 | 527.23 | 184.7 | -68.93 | -311.3 | -267.73 |
Free Cash Flow Growth | -28.85% | 185.45% | - | - | - | - |
Free Cash Flow Margin | 13.15% | 26.70% | 10.94% | -4.00% | -19.52% | -22.28% |
Free Cash Flow Per Share | 1.23 | 2.52 | 0.93 | -0.34 | -1.55 | -1.34 |
Cash Income Tax Paid | 64.39 | 53.43 | 50.85 | -24.08 | -39.23 | 4.77 |
Levered Free Cash Flow | 375.57 | 150.34 | 18.06 | -344.25 | -508.34 | -379.49 |
Unlevered Free Cash Flow | 375.57 | 150.34 | 56.13 | -302.94 | -479.76 | -373.75 |
Change in Working Capital | 286.45 | 286.45 | -115.1 | -198.38 | -191.08 | -122.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.